Pneumoconiosis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 19: Line 19:


===Age===
===Age===
*Patients of all age groups may develop [disease name].
*The incidence of pneumconiosis increases with age. <ref name="pmid32046720">{{cite journal| author=Xie M, Liu X, Cao X, Guo M, Li X| title=Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017. | journal=Respir Res | year= 2020 | volume= 21 | issue= 1 | pages= 49 | pmid=32046720 | doi=10.1186/s12931-020-1291-8 | pmc=7014719 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32046720  }} </ref>
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.  
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Race===
===Race===

Revision as of 22:08, 29 April 2021

Pneumoconiosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumoconiosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pneumoconiosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pneumoconiosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pneumoconiosis epidemiology and demographics

CDC on Pneumoconiosis epidemiology and demographics

Pneumoconiosis epidemiology and demographics in the news

Blogs on Pneumoconiosis epidemiology and demographics

Directions to Hospitals Treating Pneumoconiosis

Risk calculators and risk factors for Pneumoconiosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD

Overview

Epidemiology and Demographics

Incidence

  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

Prevalence

  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
  • The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • The incidence of pneumconiosis increases with age. [1]

Race

  • Pneumoconiosis affects all races but African Americans have a higher rate of developing the condition when exposed to the same particles. [2]

Gender

  • [Disease name] affects men and women equally.
  • [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

Developing Countries

References

  1. Xie M, Liu X, Cao X, Guo M, Li X (2020). "Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017". Respir Res. 21 (1): 49. doi:10.1186/s12931-020-1291-8. PMC 7014719 Check |pmc= value (help). PMID 32046720 Check |pmid= value (help).
  2. Cohen RA, Patel A, Green FH (2008). "Lung disease caused by exposure to coal mine and silica dust". Semin Respir Crit Care Med. 29 (6): 651–61. doi:10.1055/s-0028-1101275. PMID 19221963.

Template:WH Template:WS